Hemophilia Research Studies

ATHN2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients (PTPs) Switching Factor Products

INDICATION: Moderate to Severe Hemophilia A or Hemophilia B

ENROLLMENT AGE: 2 years and older

NCT02546622 LINK: https://clinicaltrials.gov/ct2/show/NCT02546622?term=ATHn&rank=1

Need More Information?

To get more information about any of the open clinical research studies that we have available please follow the link to the clinicaltrials.gov website or contact Anna Robinson or Kathleen Anderson in our research department by calling (517) 353-9385.

All of our clinical research studies are regulated by the Michigan State University Biomedical Institutional Review Board and the MSU Human Research Protection Program. They can be contacted by calling (517) 355-2180.